Preoperative Risk Assessment for Patients with Liver Disease

Medical Clinics of North America

Volumn 93, Issue 4, 2009, Pages 917-929

  Malik, Shahid M ^a   Ahmad, Jawad ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Cirrhosis; CTP score; Liver disease; MELD; Operative risk

Indexed keywords

DIAZEPAM; FENTANYL; HALOTHANE; ISOFLURANE; MIDAZOLAM; MORPHINE; NARCOTIC ANALGESIC AGENT; OXAZEPAM; OXYCODONE; TEMAZEPAM; VASOACTIVE AGENT;

COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG CLEARANCE; DRUG HALF LIFE; FATTY LIVER; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; LIVER FUNCTION TEST; LIVER INJURY; LIVER TRANSPLANTATION; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PORTAL HYPERTENSION; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; SURGICAL MORTALITY; SURGICAL RISK; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ALGORITHMS; ANESTHESIA, CONDUCTION; ANESTHESIA, GENERAL; ANESTHETICS; CARDIAC SURGICAL PROCEDURES; COMORBIDITY; EMERGENCY MEDICAL SERVICES; HEALTH STATUS INDICATORS; HEART DISEASES; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; LIVER DISEASES; LIVER FUNCTION TESTS; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PROGNOSIS; RISK ASSESSMENT; SURGICAL PROCEDURES, ELECTIVE;

EID: 67649389469     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2009.03.001     Document Type: Review

References (72)

1. Garrison R.N., Cryer H.M., Howard D.A., et al. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg 199 6 (1984) 648-655
2. Schemel W.H. Unexpected hepatic dysfunction found by multiple laboratory screening. Anesth Analg 55 6 (1976) 810-812
3. Hay J.E., Czaja A.J., Rakela J., et al. The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients. Hepatology 9 2 (1989) 193-197
4. Hultcrantz R., Glaumann H., Lindberg G., et al. Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases. Scand J Gastroenterol 21 1 (1986) 109-113
5. Friedman L.S., and Maddrey W.C. Surgery in the patient with liver disease. Med Clin North Am 71 3 (1987) 453-476
6. Friedman L.S. The risk of surgery in patients with liver disease. Hepatology 29 6 (1999) 1617-1623
7. Patel T. Surgery in the patient with liver disease. Mayo Clin Proc 74 6 (1999) 593-599
8. Harville D.D., and Summerskill W.H. Sugery in acute hepatitis. Causes and effects. JAMA 27 184 (1963) 257-261
9. Powell-Jackson P., Greenway B., and Williams R. Adverse effects of exploratory laparotomy in patients with unsuspected liver disease. Br J Surg 69 8 (1982) 449-451
10. Greenwood S.M., Leffler C.T., and Minkowitz S. The increased mortality rate of open liver biopsy in alcoholic hepatitis. Surg Gynecol Obstet 134 4 (1972) 600-604
11. Higashi H., Matsumata T., Adachi E., et al. Influence of viral hepatitis status on operative morbidity and mortality in patients with primary hepatocellular carcinoma. Br J Surg 81 9 (1994) 1342-1345
12. Hargrove Jr. M.D. Chronic active hepatitis: Possible adverse effect of exploratory laparotomy. Surgery 68 5 (1970) 771-773
13. Ko S., Nakajima Y., Kanehiro H., et al. Influence of associated viral hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. World J Surg 20 8 (1996) 1082-1086
14. Bruix J., Castells A., Bosch J., et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 111 4 (1996) 1018-1022
15. Azoulay D., Buabse F., Damiano I., et al. Neoadjuvant transjugular intrahepatic portosystemic shunt: a solution for extrahepatic abdominal operation in cirrhotic patients with severe portal hypertension. J Am Coll Surg 193 1 (2001) 46-51
16. Behrns K.E., Tsiotos G.G., DeSouza N.F., et al. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 2 3 (1998) 292-298
17. Brolin R.E., Bradley L.J., Taliwal R.V., et al. Unsuspected cirrhosis discovered during elective obesity operations. Arch Surg 133 1 (1998) 84-88
18. Dixon J.M., Armstrong C.P., Duffy S.W., et al. Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients. Gut 24 9 (1983) 845-852
19. Greig J.D., Krukowski Z.H., and Matheson N.A. Surgical morbidity and mortality in one hundred and twenty-nine patients with obstructive jaundice. Br J Surg 75 3 (1988) 216-219
20. Shirahatti R.G., Alphonso N., Joshi R.M., et al. Palliative surgery in malignant obstructive jaundice: prognostic indicators of early mortality. J R Coll Surg Edinb 42 4 (1997) 238-243
21. Hatfield A.R., Tobias R., Terblanche J., et al. Preoperative external biliary drainage in obstructive jaundice. A prospective control trial. Lancet 2 8304 (1982) 896-899
22. McPherson G.A., Benjamin I.S., Hodgson H.J., et al. Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg 71 5 (1984) 371-375
23. Pitt H.A., Gomes A.S., Mann L.L., et al. Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost?. Ann Surg 201 5 (1985) 545-553
24. Clements W.D., Diamond T., McCrory D.C., et al. Biliary drainage in obstructive jaundice: experimental and clinical aspects. Br J Surg 80 7 (1993) 834-842
25. Lai E.C., Mok F.P., Fan S.T., et al. Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg 81 8 (1994) 1195-1198
26. Child C.G., and Turcotte J.G. Surgery and portal hypertension. Major Probl Clin Surg 1 (1964) 1-85
27. Pugh R.N., Murray-Lyon I.M., and Dawson J.L. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60 8 (1973) 646-649
28. Mansour A., Watson W., Shayani V., et al. Abdominal operations in patients with cirrhosis: still a major surgical challenge. Surgery 122 4 (1997) 730-735
29. Ziser A., Plevak D.J., Wiesner R.H., et al. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology 90 1 (1999) 42-53
30. Malinchoc M., Kamath P.S., Gordon F.D., et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31 4 (2000) 864-871
31. Said A., Williams J., Holden J., et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 40 6 (2004) 897-903
32. Chalasani N., Kahi C., Francois F., et al. Model for end-stage liver disease (MELD) for predicting mortality in patients with acute variceal bleeding. Hepatology 35 5 (2002) 1282-1284
33. Ben-Ari Z., Cardin F., McCormick A.P., et al. A predictive model for failure to control bleeding during acute variceal haemorrhage. J Hepatol 31 3 (1999) 443-450
34. Sheth M., Riggs M., and Patel T. Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC Gastroenterol 2 (2002) 2
35. Yantorno S.E., Kremers W.K., Ruf A.E., et al. MELD is superior to King's college and Clichy's criteria to assess prognosis in fulminant hepatic failure. Liver Transpl 13 6 (2007) 822-828
36. Schmidt L.E., and Larsen F.S. MELD score as a predictor of liver failure and death in patients with acetaminophen induced liver injury. Hepatology 45 3 (2007) 789-796
37. Perkins L., Jeffries M., and Patel T. Utility of preoperative scores for predicting morbidity after cholecystectomy in patients with cirrhosis. Clin Gastroenterol Hepatol 2 12 (2004) 1123-1128
38. Suman A., Barnes D.S., Zein N.N., et al. Predicting outcome after cardiac surgery in patients with cirrhosis: a comparison of Child-Pugh and MELD scores. Clin Gastroenterol Hepatol 2 8 (2004) 719-723
39. Farnsworth N., Fagan S.P., Berger D.H., et al. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. Am J Surg 188 5 (2004) 580-583
40. Befeler A.S., Palmer D.E., Hoffman M., et al. The safety of intra-abdominal surgery in patients with cirrhosis: model for end stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome. Arch Surg 140 7 (2005) 650-654
41. Cucchetti A., Ercolani G., Vivarelli M., et al. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl 12 6 (2006) 966-971
42. Teh S.H., Nagorney D.M., Stevens S.R., et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 132 4 (2007) 1609-1611
43. Hanje A.J., and Patel T. Preoperative evaluation of patients with liver disease. Nat Clin Pract Gastroenterol Hepatol 4 5 (2007) 266-276
44. Gil A., Martinez-Regueira F., Hernandez-Lizoain J.L., et al. The role of transjugular intrahepatic portosystemic shunt prior to abdominal tumoral surgery in cirrhotic patients with portal hypertension. Eur J Surg Oncol 30 1 (2004) 46-52
45. Vinet E., Perreault P., Bouchard L., et al. Transjugular intrahepatic portosystemic shunt before abdominal surgery in cirrhotic patients: a retrospective, comparative study. Can J Gastroenterol 20 6 (2006) 401-404
46. Klemperer J.D., Ko W., Krieger K.H., et al. Cardiac operation in patients with cirrhosis. Ann Thorac Surg 65 1 (1998) 85-87
47. Filsoufi F., Salzberg S.P., Rahmanian P.B., et al. Early and late outcome of cardiac surgery in patients with liver cirrhosis. Liver Transpl 13 7 (2007) 990-995
48. Gaudino M., Santarelli P., Bruno P., et al. Palliative coronary artery surgery in patients with severe noncardiac diseases. Am J Cardiol 80 10 (1997) 1351-1352
49. Demetriades D., Constantinou C., Salim A., et al. Liver cirrhosis in patients undergoing laparotomy for trauma: effect on outcomes. J Am Coll Surg 199 4 (2004) 538-542
50. Clavien P.A., Petrowsky H., DeOliveira M.L., et al. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 356 15 (2007) 1545-1559
51. MacIntosh E.L., and Minuk G.Y. Hepatic resection in patients with cirrhosis and hepatocellular carcinoma. Surg Gynecol Obstet 174 3 (1992) 245-254
52. Wu C.C., Ho W.L., Yeh D.C., et al. Hepatic resection of hepatocellular carcinoma in cirrhotic livers: is it unjustified in impaired liver function?. Surgery 120 1 (1996) 34-39
53. Bruix J. Treatment of hepatocellular carcinoma. Hepatology 25 2 (1996) 259-262
54. Cohnert T.U., Rau H.G., Buttler E., et al. Preoperative risk assessment of hepatic resection for malignancy disease. World J Surg 21 4 (1997) 396-400
55. Capussotti L., and Polastri R. Operative risks of major hepatic resections. Hepatogastroenterology 45 19 (1998) 184-190
56. Mor E., Kaspa R.T., Sheiner P., et al. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med 129 8 (1998) 643-653
57. Di Bisceglie A.M., Carither Jr. R.L., and Gores G.J. Hepatocellular carcinoma. Hepatology 28 4 (1998) 1161-1165
58. Wu C.C., Yeh D.C., Lin M.C., et al. Improving operative safety for cirrhotic liver resection. Br J Surg 88 2 (2001) 210-215
59. Grazi G.L., Ercolani G., Pierangeli F., et al. Improved results of liver resection for hepatocellular carcinoma give the procedure added value. Ann Surg 234 1 (2001) 71-78
60. Gelman S., Fowler K.C., and Smith L.R. Liver circulation and function during isoflurane and halothane anesthesia. Anesthesiology 61 6 (1984) 726-730
61. Kenna J.G. Immunoallergic drug-induced hepatitis: lessons from halothane. J Hepatol 26 1 (1997) 5-12
62. Daghfous R., el Aidli S., Sfaxi M., et al. Halothane-induced hepatitis: 8 case reports. Tunis Med 81 11 (2003) 874-878
63. Gut J. Molecular basis of halothane hepatitis. Arch Toxicol Suppl 20 (1998) 3-17
64. Delco F., Tchambaz L., Schlienger R., et al. Dose adjustment in patients with liver disease. Drug Saf 28 6 (2005) 529-545
65. Tegeder I., Lotsch J., and Geisslinger G. Pharmacokinetics of opioids in liver disease. Clin Pharmacokinet 37 1 (1999) 17-40
66. Ochs H.R., Greenblatt D.J., Eckardt B., et al. Repeated diazepam dosing in cirrhotic patients: cumulation and sedation. Clin Pharmacol Ther 33 4 (1983) 471-476
67. Ghabrial H., Desmond P.V., Watson K.J., et al. The effects of age and chronic liver disease on the elimination of temazepam. Eur J Clin Pharmacol 30 1 (1986) 93-97
68. Pentikainen P.J., Valisalmi L., Himberg J.J., et al. Pharmacokinetics of midazolam following intravenous and oral administration in patients with chronic liver disease and in healthy subjects. J Clin Pharmacol 29 3 (1989) 272-277
69. Darling J.R., Murray J.M., Hainsworth A.M., et al. The effect of isoflurane or spinal anesthesia on indocyanine green disappearance rate in the elderly. Anesth Analg 78 4 (1994) 706-709
70. Groszmann R.J. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology 20 5 (1994) 1359-1363
71. Moller S., and Henriksen J.H. Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart 87 1 (2002) 9-15
72. Gelman S.I. Disturbances in hepatic blood flow during anesthesia and surgery. Arch Surg 111 8 (1976) 881-883